ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,569Medicare Part D Prescriptions Filled, Including Refills

Rank: 145 out of 783

$433K Total Retail Price of All Prescriptions

Rank: 326 out of 783

355 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 355 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 557 500 1 4
WARFARIN SODIUM 515 504 2 10
HYDROCHLOROTHIAZIDE 438 425 3 12
SIMVASTATIN 420 402 4 3
OMEPRAZOLE 370 334 5 6
HYDROCODONE-ACETAMINOPHEN 351 320 S3 6 2
METFORMIN HCL 343 324 7 8
LEVOTHYROXINE SODIUM 317 312 8 1
METOPROLOL SUCCINATE 307 302 9 13
FUROSEMIDE 298 292 10 7
POTASSIUM CHLORIDE 289 277 11 16
AMLODIPINE BESYLATE 283 281 12 5
LOSARTAN POTASSIUM 261 249 13 18
GLIMEPIRIDE 223 217 14 34
CITALOPRAM HBR 193 182 15 19
DIOVAN 161 157 16 49
METOPROLOL TARTRATE 148 145 17 9
FAMOTIDINE 140 130 18 55
ZOLPIDEM TARTRATE 136 126 19 23
MELOXICAM 130 128 20 37
TAMSULOSIN HCL 122 122 21 26
ALENDRONATE SODIUM 119 119 22 25
ATORVASTATIN CALCIUM 118 114 23 11
CLONIDINE HCL 115 115 24 60
ALLOPURINOL 102 101 25 31
PRAVASTATIN SODIUM 102 85 25 14
DIGOXIN 101 101 27 61
ATENOLOL 99 99 28 17
DONEPEZIL HCL 99 99 28 24
ENALAPRIL MALEATE 99 96 28 68
PAROXETINE HCL 96 90 31 69
LANTUS 94 86 32 38
KLOR-CON 10 92 88 33 102
AMOXICILLIN 91 89 34 116
RANITIDINE HCL 90 75 35 44
CLOPIDOGREL 88 75 36 29
NAPROXEN 82 60 37 104
TRAMADOL HCL 79 63 38 20
PANTOPRAZOLE SODIUM 78 62 39 30
ISOSORBIDE MONONITRATE ER 72 56 40 40
GABAPENTIN 70 66 41 15
SERTRALINE HCL 67 67 42 22
LOSARTAN-HYDROCHLOROTHIAZIDE 66 55 43 53
DILTIAZEM ER 63 58 44 153
CIPROFLOXACIN HCL 61 59 45 62
PLAVIX 60 51 46 51
GEMFIBROZIL 59 47 47 105
SYNTHROID 56 56 48 47
POLYETHYLENE GLYCOL 3350 56 55 48 43
CRESTOR 55 55 50 27
DOXYCYCLINE HYCLATE 54 54 51 112
MECLIZINE HCL 54 54 51 146
PREDNISONE 52 51 53 36
DILTIAZEM HCL 52 52 53 207
DILTIAZEM 24HR CD 51 51 55 118
NAMENDA 50 50 56 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.